Epic Sciences wins federal grant to develop lung cancer test

01/25/2013 | GenomeWeb Daily News (free registration)

The NIH and the National Cancer Institute awarded Epic Sciences a Small Business Innovation Research grant to develop a test to detect and specify circulating tumor cells in lung cancer patients. Epic previously won a Phase I grant. The grants total $1.2 million.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL